Patent Term Adjustment will provide market exclusivity in the United States into 2040 for all therapeutic indications OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology...
Leading AI-driven dynamic decision intelligence platform to enhance network visibility and accelerate decision-making ParkourSC, a leader in AI-driven supply chain dynamic decision intelligence solutions, announced...
Proprietary safety features support advanced therapies across a wide range of patients and ease the burden on caregivers Agiliti, a leading manufacturer and provider of...
Turacoz highlights the growing integration of AI, human insight, and patient involvement in medical communications, while emphasizing the importance of integrity and transparency. With the...
Marks significant expansion of initiative to help health systems access critical, at-risk medications for patients Cencora, a global healthcare company, has significantly expanded the number...
GE HealthCare (Nasdaq: GEHC) today announced a $138 million investment to expand its Carrigtohill, Cork contrast media fill and finish manufacturing site in Ireland. A...
Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co. Ltd., and Swixx BioPharma AG today announced that the Croatian National Health Insurance...
Researchers invited to gain early access to next-generation platform to optimize functional single-cell analysis workflows across expanded applications in life science R&D Sphere Fluidics, a...
Leading healthcare IT research and vendor marketplace, Elion, announced today the release of its latest report, “AI Clinician Copilots: Technology, Market Trends, and Key Differentiators.” This in-depth...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company“) announced that the Company received marketing authorization in China from National Medical Products Administration (NMPA) for the programmed cell death ligand...